In early atherosclerosis, smooth muscle cells migrate from the media to the intima of the arterial wall, where they proliferate and endocytose various lipoproteins, rosulting in the formation of foam cells (1, 2) . During the atherosclerotic process, smooth muscle cells undergo structural and functional changes (2). Although the precise mechanism of the phenotypic change is not fully understood, the involvement of various cytokines and growth factors was proposed in this phenotypic change of smooth muscle cells (1, 2).
In the arterial wall, various cytokines, such as interleukin-1, interleukin-6, tumor necrosis factor a , interferons and colony stimulating factors, are reported to be synthesized and secreted by vascular cell components (3) (4) (5) (6) . Among the cytokines, M-CSF, an 85 kDa homodimeric glycoprotein, specifically promotes growth and differentiation of the monocyte-macrophage lineage and activates various functions of mature macrophages (7) (8) (9) . Recently, we demonstrated that M-CSF enhances scavenger receptor activity in human monocyte-derived macrophages, suggesting the possible involvement of M-CSF in the atherosclerotic process (10). The effects of M-CSF are mediated through binding to specific, high-affinity surface receptors encoded by the c-fms proto-oncogene (11). In the present study, two different phenotypes of smooth muscle cells were isolated : one from an experimental rabbit model of arteriosclerosis and another from normal arterial wall. Expression of c-fms was found in smooth muscle cells isolated from experimental arteriosclerosis.
Experimental Procedures

Materials
Sodium [125I] iodide and [3H]-thymidine were purchased from ICN Radiochemicals. 125I-PDGF-BB homodimer was purchased from Amersham. Recombinant human M-CSF was a purified product obtained from Morinaga Milk Industry Co., Ltd. (Tokyo, Japan). PDGF-BB homodimer was purchased from Genzyme. All other chemicals were of analytical grade.
Cells
Intimal smooth muscle cells were isolated and cultured as described previously (12 Results lmmunocytochemical analysis We performed immunocytochemical studies to characterize two different types of smooth muscle cells ; intimal smooth muscle cells were isolated from thickened intima of cannulated aorta and medial smooth muscle cells were isolated from normal intact artery using monoclonal antibodies specific for muscle cells and macrophages.
As shown in Fig. 1 , intimal smooth muscle cells reacted with antibody specific to muscle cells (HHF 35), but failed to react with antibody specific to rabbit macrophages (RAM 11)(14). This indicated that the intimal smooth muscle cells that we isolated were immunologically different from macrophages, and similar to medial smooth muscle cells.
M-CSF receptor mRNA
In smooth muscle cells M-CSF receptor encoded by c-fms was detected using the cDNA probe for v-fms (16). Northern blot hybridization analysis of RNA obtained from intimal smooth muscle cells demonstrated appreciable amounts of M-CSF receptor mRNA with a length of 4.5 kb, whereas there was no mRNA detected in normal medial smooth muscle cells. To determine M-CSF receptor mRNA levels in either intimal smooth muscle cells or medial smooth muscle cells, we utilized the competitive polymerase chain reaction (PCR) method. As shown in Fig. 2 (Fig . 3) . We also found that iodinated PDGF (BB) bound to both intimal and medial smooth muscle cells ; Bmax in binding of iodinated PDGF (BB) to intimal smooth muscle cells (631 f mol/mg cell protein) was 1.23-fold greater than that to medial smooth muscle cells (512 f mol/mg cell protein) . Binding affinities were not different between the two cell types ; 535 pM for medial smooth muscle cells and 464 pM for intimal smooth muscle cells. These results indicated that intimal smooth muscle cells have both M-CSF receptor and PDGF receptor on the cell surface , whereas normal medial smooth muscle cells lack M-CSF receptor .
We studied the effects of M-CSF on the growth of either intimal or medial smooth muscle cells .
[3H]-thymidine uptake and the cell growth curve (data not shown) indicated that enhanced proliferation in response to M-CSF 
Discussion
The action of M-CSF was mediated through binding to specific, high-affinity surface receptors encoded by the c-fms proto-oncogene (11), and the expression of M-CSF receptor on cells generally coincided with their differentiation to the monocyte-macrophage lineage. M-CSF receptors have not been demonstrated in normal vascular smooth muscle cells. In the present study, the expression of c-fms was demonstrated in smooth muscle cells isolated from an experimental arteriosclerosis (intimal smooth muscle cells) with an mRNA level of 10,000-fold that of medial smooth muscle cells. The immunocytochemical study showed that intimal smooth muscle cells were immunologically different from macrophages, but similar to normal medial smooth muscle cells as shown in Fig. 1 .
It is well known that macrophages endocytose acetylated LDL through a scavenger receptor in vitro (19). As shown in Figs. 3 Furthermore, we demonstrated that both M-CSF and PDGF bind to intimal smooth muscle cells, and induce cell growth. It was proposed that PDGF regulates the proliferation and migration of vascular smooth muscle cells via specific receptors (1, 2). PDGF receptors and M-CSF receptors are generally expressed in a mutually exclusive manner, i.e., the PDGF receptor is expressed on mesenchymal cells and the M-CSF receptor is expressed primarily on monocyte-macrophages.
Roberts et al. (22) reported the tandem linkage of these genes and suggested that the close approximation of the two genes may suppress c-fms transcription in mesenchymal cells. Taking into account the c-fms and scavenger receptor expression in intimal smooth muscle cells, our these Tandem linkage of human CSF-1 receptor (c-fms) and PDGF receptor genes. Cell, 55 : 665-671, 1988 
